Evidence map›Paper›PMID 40632787›Full record

ArticleJournal of the American Chemical Society2025

Data Science-Guided Development of Deoxyfluorination Reagents with Enhanced Reactivity, Practicality, and Safety.

Madeline E Ruos, Natalie P Romer, Julie A Deichert, Lady Mae Alabanza, Shivaani S Gandhi, Giselle Z Brown, Richard C Walroth, Karissa Cruz, Francis Gosselin, Allen Y Hong and 2 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Deoxyfluorination of Hydroxy-Substituted Boronates.ACS organic & inorganic Au · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Madeline E RuosDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, California 90095, United States.ORCID 0009-0007-6955-8642
Natalie P RomerDepartment of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
Julie A DeichertDepartment of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.
Lady Mae AlabanzaDepartment of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.
Shivaani S GandhiDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0003-1825-5450
Giselle Z BrownDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, California 90095, United States.
Richard C WalrothDepartment of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.
Karissa CruzDepartment of Synthetic Molecule Analytical Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.
Francis GosselinDepartment of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.ORCID 0000-0001-9812-4180
Allen Y HongDepartment of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.ORCID 0000-0002-4691-548X
Matthew S SigmanDepartment of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
Abigail G DoyleDepartment of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0002-6641-0833

Funding

Data Science Guided Organic Reaction DevelopmentR35GM136271 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MATTHEW S SIGMAN · 2020 to 2026
$3.5M
NMR Console and Prodigy CryoProbeS10OD028644 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GARG, NEIL K · 2021 to 2021
$600k
NIGMS NIH HHS R35 GM136271NIH HHS S10 OD028644
6 · The paper itself

Abstract

We report the discovery and development of several new (hetero)aryl sulfonyl fluoride reagents that have enhanced deoxyfluorination reactivity, improved physical properties, and excellent safety profiles compared to those of PyFluor and other fluorination reagents such as PBSF and DAST. To select structurally diverse reagents, we computed a virtual library of (hetero)aryl sulfonyl fluorides and leveraged training set design principles to broadly survey structure-activity relationships in a model deoxyfluorination reaction. We developed predictive models to optimize sulfonyl fluoride reagents for the deoxyfluorination of a key intermediate used in the synthesis of RIPK1 inhibitor GDC-8264. The top-performing reagents demonstrated broad applicability across diverse alcohol substrate classes, including complex natural products and active pharmaceutical ingredients, highlighting the power of data science-enabled approaches in reagent development.

Indexed as

Sulfinic AcidsHalogenationHumansIndicators and ReagentsMolecular StructureStructure-Activity RelationshipIndicators and ReagentsSulfinic Acidssulfuryl fluoride

Identifiers

PMID40632787
PMCPMC12422589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.